MicroPort EP(688351)2025-01-24 10:15Financial Performance Expectations - The company expects a net profit attributable to shareholders of the parent company for 2024 to be between 47 million and 56 million RMB, an increase of 41.31 million to 50.31 million RMB compared to the previous year, representing a year-on-year increase of 726.23% to 884.44%[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is expected to be between 4.7 million and 5.6 million RMB, indicating a turnaround from a loss in the previous year[3]. - The previous year's net profit attributable to shareholders was 5.6885 million RMB, and the net profit after deducting non-recurring gains and losses was -35.4702 million RMB[5]. - There are no significant uncertainties affecting the accuracy of this earnings forecast as of the announcement date[9]. - The forecast data is preliminary and the specific financial data will be disclosed in the audited 2024 annual report[10]. Sales and Market Development - The company has seen a significant increase in sales of high-value consumables, including TrueForce® pressure monitoring RF ablation catheters, IceMagic® cryoablation series products, and FireMagic® microelectrode RF ablation catheters[7]. - The cumulative usage of TrueForce® pressure catheters has exceeded 5,000 cases since its launch, with commercialization in over 20 countries, accelerating the internationalization of domestic electrophysiological high-end medical devices[7]. - The overseas business revenue is expected to grow by over 60% year-on-year in 2024, further increasing its share of the company's total revenue[7]. - The company plans to continue strengthening market development, enhancing technological innovation, optimizing business structure, and improving internal management for higher quality growth in 2025[7]. Government Support and Financial Management - The company has received various government subsidies and generated investment income from cash management using raised and self-owned funds during the reporting period[8].